Inari Medical Analyst Ratings
BenzingaApr 12 11:59 ET
Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target
BenzingaApr 12 12:00 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inari Medical (NARI) and Roivant Sciences (ROIV)
TipRanksApr 3 05:03 ET
Inari Medical Analyst Ratings
BenzingaMar 22 09:07 ET
Needham Reiterates Buy on Inari Medical, Maintains $72 Price Target
BenzingaMar 6 07:46 ET
Inari Medical Analyst Ratings
BenzingaMar 6 07:44 ET
Inari Medical Buy Rating Justified by Industry-Standard Physician Payments and Resilient Sector Trends
TipRanksMar 6 05:35 ET
Piper Sandler Cuts Inari to Neutral; Cites Slowing Growth, DOJ Probe
Seeking AlphaMar 1 16:03 ET
Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
BenzingaFeb 29 11:01 ET
Inari Medical (NARI) Gets a Hold From Truist Financial
TipRanksFeb 29 07:21 ET
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating
MT NewswiresFeb 29 07:20 ET
Inari Medical: Strong Buy Rating Amidst Long-Term Growth Prospects and Strategic Initiatives
TipRanksFeb 29 06:45 ET
Inari Medical (NARI) Receives a Hold From Truist Financial
TipRanksJan 30 21:25 ET
Needham Starts Inari at Buy, Citing Improving Operating Margins
Seeking AlphaJan 23 16:32 ET
Inari Medical Analyst Ratings
BenzingaJan 23 06:46 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Definitive Healthcare Corp (DH), Anavex Life Sciences (AVXL) and Inari Medical (NARI)
TipRanksJan 22 12:50 ET
Inari Medical: Strong Q4 Performance and Promising Growth Trajectory Justify Buy Rating
TipRanksJan 10 05:40 ET
BTIG Remains a Buy on Inari Medical (NARI)
TipRanksJan 7 05:38 ET
Piper Sandler Keeps Their Buy Rating on Inari Medical (NARI)
TipRanksJan 5 07:55 ET
Inari Medical Analyst Ratings
BenzingaDec 22, 2023 09:50 ET
No Data
No Data